1 / 28

Cohort and case-control designs

Summer Course: Introduction to Epidemiology. August 28, 1045-1215. Cohort and case-control designs. Dr. N. Birkett, Department of Epidemiology & Community Medicine, University of Ottawa. Session Overview. Review basic features of these two designs Discuss advantages and disadvantages

chynna
Download Presentation

Cohort and case-control designs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Summer Course:Introduction to Epidemiology August 28, 1045-1215 Cohort and case-control designs Dr. N. Birkett, Department of Epidemiology & Community Medicine, University of Ottawa

  2. Session Overview • Review basic features of these two designs • Discuss advantages and disadvantages • Key methodological features in implementation of the designs.

  3. General (1) • Our main focus is on etiology and studies of relationships • External validity is not big issue • A much bigger issue for cross-sectional studies • A big issue for health care delivery, etc. • Methods of Data Collection • Structured vs. unstructured interviews • Qualitative vs. quantitative methods • Personal interview • Mail & telephone surveys

  4. Cohort (1) • Key feature is that subjects are followed from before they became ill until they get the outcome • Two main methods of subject selection • Separate exposed and unexposed groups • Select a group of people with the exposure of interest and • Select a group of people without the exposure of interest • Select a group of people with a range of exposure experiences • Follow all subjects up to determine if they develop new cases of the outcome. • Compare the incidence of the outcome in each group.

  5. Prospective Concurrent Historical Retrospective Mixed Historical Ambidirectional

  6. Advantages of Cohort Studies • Demonstrate clear temporal relationship • Allow direct calculation of incidence rates and risks • Allow multiple outcomes to be studied in one project • Allow multiple exposures to be studied in one project. • Provides some indication of disease latency or the incubation period (sometimes) • Suitable for studying rare exposures • Reduced potential for bias • Eliminates recall bias • Controls exposure misclassification.

  7. Disadvantages of Cohort studies • Often require large sample sizes and long follow-up times. • High cost and complexity. • Bias due to loss to follow-up • How to handle changes in exposure status during follow-up • Also a problem in case-control studies but usually ignored. • Lack of available information for creation of exposure history in historical cohort studies. • Outcome assessment misclassification/bias if staff not blinded to exposure status • Advances in technology or medical knowledge can invalidate the outcome assessment, or even the whole study hypothesis.

  8. Key Design Points for Cohort Studies • Selecting the cohort • Determining exposure status • Determining outcome status • Healthy worker effect • Studies of prognosis require Inception Cohort.

  9. Cohorts: Selecting the Cohort (1) • Subjects must be: • Free of outcome at time of entry; • At risk of developing the study outcome • General population • Members of specific groups (e.g. unions, schools, professional organisations) • Special exposed groups (environmental)

  10. Cohorts: Selecting the Cohort (2) • Internal vs. External comparison group • Internal uses people within the cohort • Is generally the best option. • External goes outside the cohort. • External group can be hard to find due to problems in lack of comparability • General population may be a poor choice: • Will include people with exposure

  11. Cohorts: Determining Exposure Status • Need to consider change in exposure over time. • Interviews • Self-completed questionnaires • Body specimens (e.g. blood, hair, toenail clippings) • Biomarkers (molecular epidemiology) • Administrative records • Company records • Birth records • Hospital/MD records • environmental monitoring data. • Physical Examination • Environmental tests • Job descriptions • Job exposure matrix

  12. Cohorts: Determining Outcome Status • Self-report • validity • completeness • Administrative records • Vital statistics • Registries • Medical records • Physical examination • Biological samples

  13. Cohorts: Ontario Health Study • e-mail and web sites to collect basic information of everyone • goal is to recruit all people living in Ontario • Sub-set approached for a more detailed interview • Sub-sub-set approached for physical examination, blood samples, MRI’s, etc. • Has over 200,000 registrants • Target is 1,000,000+

  14. Case-control (1) • Key feature is that subjects are selected after they have developed the outcome of interest. • Interviews are done after the fact • Limits the potential for some measures in etiologically relevant time periods • biomarkers • psychological state • Subject to biases • Need a comparison group (control group or reference group) • Choosing a suitable group is a major challenge. • Can not compute incidence in case-control study.

  15. Advantages of case-control studies • Relatively quick and cheap • not always • depends on the design used • Appropriate for studying rare outcomes. • Require a smaller number of subjects than cohort study • assuming you can find enough cases • Allows study of multiple potential exposure factors in the same study

  16. Disadvantages of case-control studies • Can only study one outcome per study • Cannot determine incidence directly • Except in special circumstances. • Not appropriate for studying rare exposures. • Higher risk of biases in exposure estimation, etc. • Selection of appropriate comparison group can be hard. • They have a bad reputation • Complex design and methodological features • Finding controls is getting harder than finding cases

  17. Key Design Points: Case-control Studies • Selecting the cases • Selecting the controls • Determining exposure status • Sample size and power.

  18. Case control studies: Selecting the Cases (1) • Need a clear case definition (eligibility criteria) • How to find cases? • Hospital-based vs. population-based. • Population based in better but can be hard to find all cases in a pre-defined population. • Population-based registry can be useful.

  19. Case control studies: Selecting the Cases (2) • Retrospective vs. prospective case identification • retrospective is faster • prospective is better • changes in diagnostic approaches, referral patterns, etc. can be a problem with retro. method • Incident vs. prevalent cases • Incident cases are MUCH better

  20. Case control studies: Selecting Controls (1) Without controls, there can be no case-control studies but with the wrong controls, there can only be regrettable case-control studies.Oleckno • This is the biggest challenge is designing a case-control study!! • Should represent the source population which gave rise to the cases. • In a hospital case-control study, do not select as a control group people with diagnoses which are known to be related to the exposure. • Just finding candidate controls is becoming a big challenge • privacy laws • lack of public interest in research

  21. Case control studies: Selecting Controls (2) • Some key questions about control groups • Do the controls come from the same source population as the cases? • Are the controls similar to the cases with respect to potentially confounding factors? (matching; stratified analysis) • Have any restrictions or exclusions been applied to both cases and controls? • Are hospital controls taken from groups which are not associated with the exposure of interest? • Have the controls been selected from the same time period as the cases?

  22. Case control studies: Determining Exposure Status • Determine the etiologically relevant time period. • Can we measure exposure at that time? • Interviewer bias • Use the same method in cases and controls. • blinding • Recall Bias • Hard to prevent/control • Blind subjects to objectives • Include ‘lie detection’ questions • Use validated questionnaires • Use alternative sources of exposure information • records • biomarkers

  23. Case control studies: Sample Size and Power • May need large sample size, especially if studying interactions • Multiple controls per case • Useful mainly when controls are more available than cases or are cheaper to study • 4 controls per case is the largest ratio usually used. • In ‘nested case-control studies in pharmacoepidemiology, can use up to 10 or 20 controls per case

  24. Summary • Both cohort and case-control studies have strengths and weaknesses • Case-control studies are harder to design well. • Cohort studies are generally preferred but take also much longer to complete and are much more expensive.

More Related